Colgate-Palmolive (NYSE:CL) Vice Chairman Franck J. Moison sold 44,418 shares of the company’s stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $69.87, for a total value of $3,103,485.66. Following the sale, the insider now owns 211,048 shares of the company’s stock, valued at approximately $14,745,923.76. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Colgate-Palmolive (NYSE:CL) traded up $0.11 during midday trading on Tuesday, hitting $70.30. The company had a trading volume of 3,373,435 shares, compared to its average volume of 4,439,941. Colgate-Palmolive has a fifty-two week low of $67.19 and a fifty-two week high of $77.91. The company has a quick ratio of 0.34, a current ratio of 0.47 and a debt-to-equity ratio of 24.42. The firm has a market cap of $61,510.00, a PE ratio of 30.83, a PEG ratio of 2.58 and a beta of 0.75.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, hitting the consensus estimate of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The business had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. During the same quarter in the previous year, the firm earned $0.75 EPS. The firm’s revenue was up 4.6% compared to the same quarter last year. sell-side analysts predict that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.
Several research firms have recently issued reports on CL. Citigroup upped their price target on Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 30th. Jefferies Group reiterated a “hold” rating and set a $79.00 price target on shares of Colgate-Palmolive in a research note on Friday, January 26th. BNP Paribas downgraded Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research note on Tuesday, January 30th. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Monday, January 15th. Finally, Morgan Stanley decreased their price target on Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating for the company in a research note on Tuesday, October 31st. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $77.71.
Several hedge funds and other institutional investors have recently bought and sold shares of CL. Renaissance Technologies LLC raised its holdings in Colgate-Palmolive by 42.4% in the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock valued at $723,020,000 after acquiring an additional 2,903,800 shares in the last quarter. APG Asset Management N.V. raised its holdings in Colgate-Palmolive by 243.0% in the 3rd quarter. APG Asset Management N.V. now owns 4,070,784 shares of the company’s stock valued at $296,557,000 after acquiring an additional 2,884,100 shares in the last quarter. Harding Loevner LP raised its holdings in Colgate-Palmolive by 92.0% in the 3rd quarter. Harding Loevner LP now owns 4,742,752 shares of the company’s stock valued at $176,329,000 after acquiring an additional 2,272,675 shares in the last quarter. First Eagle Investment Management LLC raised its holdings in Colgate-Palmolive by 35.8% in the 3rd quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock valued at $483,837,000 after acquiring an additional 1,750,417 shares in the last quarter. Finally, Vanguard Group Inc. raised its holdings in Colgate-Palmolive by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock valued at $5,031,602,000 after acquiring an additional 1,621,392 shares in the last quarter. 72.85% of the stock is owned by institutional investors and hedge funds.
WARNING: “Colgate-Palmolive (CL) Vice Chairman Sells $3,103,485.66 in Stock” was posted by American Banking News and is the property of of American Banking News. If you are accessing this article on another site, it was stolen and republished in violation of US & international copyright legislation. The correct version of this article can be viewed at https://www.americanbankingnews.com/2018/02/13/colgate-palmolive-cl-vice-chairman-sells-3103485-66-in-stock.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.